Lower negative symptom scores among cannabis-dependent patients with schizophrenia-spectrum disorders: Preliminary evidence from an African American first-episode sample

Schizophrenia Research

Volumn 71, Issue 1, 2004, Pages 61-64

  Compton, Michael T ^a,b   Furman, Andrew C ^a   Kaslow, Nadine J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GRADY MEMORIAL HOSPITAL   (United States)

Author keywords

African American first episode sample; Cannabis dependence; Schizophrenia spectrum disorder

Indexed keywords

CANNABIS;

ADULT; AFRICAN AMERICAN; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; HOSPITALIZATION; HUMAN; MENTAL DISEASE; NEGATIVE SYNDROME; PILOT STUDY; POSITIVE SYNDROME; PRIORITY JOURNAL; SAMPLE; SCHIZOPHRENIA; SCORING SYSTEM; SUBSTANCE ABUSE; SYMPTOM;

ADOLESCENT; ADULT; AFRICAN AMERICANS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MARIJUANA ABUSE; PILOT PROJECTS; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS;

EID: 4444326340     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2004.01.005     Document Type: Article

References (18)

1. Addington J., Addington D. Impact of an early psychosis program on substance use. Psychiatr. Rehabil. J. 25:2001;60-67
2. Cantwell R., Brewin J., Glazebrook C., Dalkin T., Fox R., Medley I., Harrison G. Prevalence of substance misuse in first-episode psychosis. Br. J. Psychiatry. 174:1999;150-153
3. Dervaux A., Laqueille X., Bourdel M.C., Leborgne M.H., Olie J.P., Loo H., Krebs M.O. Cannabis and schizophrenia: demographic and clinical correlates. Encephale. 29:2003;11-17
4. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). 1995;New York State Psychiatric Institute, Biometrics Research, New York, NY
5. Hambrecht M., Häfner H. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. Aust. N. Z. J. Psychiatry. 34:2000;468-475
6. Horan W.P., Blanchard J.J. Neurocognitive, social, and emotional dysfunction in deficit syndrome schizophrenia. Schizophr. Res. 65:2003;125-137
7. Joyal C.C., Hallé P., Lapierre D., Hodgins S. Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia. Schizophr. Res. 63:2003;297-299
8. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 13:1987;261-276
9. Kirkpatrick B., Amador X.F., Flaum M., Yale S.A., Gorman J.M., Carpenter W.T., Tohen M., McGlashan T. The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug use. Schizophr. Res. 20:1996;69-77
10. Kirkpatrick B., Messias E.M., Tek C. Substance abuse and the heterogeneity of schizophrenia: a population-based study. Schizophr. Res. 62:2003;293-294
11. Lysaker P., Bell M., Beam-Goulet J., Milstein R. Relationship of positive and negative symptoms to cocaine abuse in schizophrenia. J. Nerv. Ment. Dis. 182:1994;109-112
12. Mueser K.T., Bellack A.S., Blanchard J.J. Comorbidity of schizophrenia and substance abuse: implications for treatment. J. Consult. Clin. Psychol. 60:1992;845-856
13. Mueser K.T., Drake R.E., Wallach M.A. Dual diagnosis: a review of etiological theories. Addict. Behav. 23:1998;717-734
14. Mueser K.T., Yarnold P.R., Rosenberg S.D., Swett C., Miles K.M., Hill D. Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups. Schizophr. Bull. 26:2000;179-192
15. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA. 264:1990;2511-2518
16. Salyers M.P., Mueser K.T. Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia. Schizophr. Res. 48:2001;109-123
17. Scheller-Gilkey G., Thomas S.M., Woolwine B.J., Miller A.H. Increased early life stress and depressive symptoms in patients with comorbid substance abuse and schizophrenia. Schizophr. Bull. 28:2002;223-231
18. Strakowski S.M., Tohen M., Stoll A.L., Faedda G.L., Mayer P.V., Kolbrener M.L., Goodwin D.C. Comorbidity in psychosis at first hospitalization. Am. J. Psychiatry. 150:1993;752-757